428 rows
| No. | Description of goods | Goods code | |
|---|---|---|---|
| No. | Name of the active ingredient | Form of use | Goods code |
| 1 | Finished drug product containing: Dextrose monohydrate; Sodium chloride; Sodium lactate; Potassium chloride; Calcium chloride.2H2O | Intravenous infusion solution | 3004. 90. 91 |
| 2 | Finished pharmaceutical product containing: Tinidazole; Clarithromycin; Lansoprazole | Oral form | 3004.20.31 |
| 3 | Finished pharmaceutical product containing: Glucosamine sulfate potassium chloride; Manganese Amino acid chelate; Zingiber officinale rhizome ext. | Capsule | 3004.90.99 |
| 4 | Finished pharmaceutical product containing: Diphenhydramine HCl; Ammonium Chloride; Sodium Citrate; Menthol | Syrup | 3004.90.59 |
| 5 | Finished pharmaceutical product containing: Pancreatin; Simethicone | Enteric-coated film tablet | 3004.90.99 |
| 6 | Finished drug product containing: Biodiastase 2000 I; Lipase II; Cellulase AP3 II; Simethicone | Film-coated tablet | 3004.90.99 |
| 7 | Finished pharmaceutical product containing: Tobramycin; Dexamethasone | Eye drops | 3004.20.99 |
| 8 | Finished pharmaceutical product containing: Lactobacillus acidophilus (sp. L. gasseri); Bifidobacterium infantis; Enterococcus faecium | Hard capsule | 3004.90.99 |
| 9 | Finished drug product containing: Ursodeoxycholic acid; Thiamine nitrate; Riboflavin | Soft capsule | 3004.50. 91 |
| 10 | Finished drug product containing: Cefoperazone; Sulbactam | Powder for injection | 3004.20.99 |
| 11 | Finished drug product containing: Desloratadine; Pseudoephedrine | Extended-release tablet | 3004.42.00 |
| 12 | Finished pharmaceutical product containing: Fluocinolone acetonide; Neomycin sulphate[1] | Skin cream | 3004.32.40 |
| 13 | Finished pharmaceutical product containing: Dipyridamole; Acetylsalicylic acid | Extended-release capsule | 3004.90.89 |
| 14 | Finished drug product containing Paracetamol; Phenylephrine hydrochloride; Ascorbic acid | Powder for oral use | 3004.90.51 |
| 15 | Finished pharmaceutical product containing: Rifampin; Isoniazid | Film-coated tablet | 3004.20.91 |
| 16 | Finished pharmaceutical product containing: Rifampicin; Isoniazid; Ethambutol hydrochloride | Film-coated tablet | 3004.20.91 |
| 17 | Finished pharmaceutical product containing: Telmisartan 40mg; Hydrochlorothiazide 12,5mg | Tablet | 3004.90.89 |
| 18 | Finished pharmaceutical product containing: Aluminium phosphate gel; Magnesium oxide | Suspension | 3004.90.99 |
| 19 | Finished drug product containing: Cefepime hydrochloride; Arginine | Powder for injection | 3004.20.99 |
| 20 | Finished pharmaceutical product containing: Piperacillin Sodium; Tazobactam Sodium | Powder for injection | 3004.10.19 |
| 21 | Finished drug product containing: Salts of diatrizoic acid: meglumine salt; | Injection solution | 3004.90.99 |
| 22 | Finished pharmaceutical product containing: Lopinavir; Ritonavir | All forms | 3004.90.82 |
| 23 | Finished pharmaceutical product containing: L-Isoleucine; L-Leucine; L-Lysine acetate; L-Methionine; L-Phenylalanine; L-Threonine; L-Tryptophan; L-Valine; L-alanine, L-Arginine; L-Aspartic acid; L-Glutamic acid; L-Histidine; L-Proline,... | Intravenous infusion solution | 3004.90.99 |
| 24 | Finished pharmaceutical product containing: L-Isoleucine; L-Leucine; Lysine Hydrochloride; L-Methionine; L-Phenylalanine; L-Threonine; L-Tryptophan; L-Valine; L-alanine; L-Arginine; L-Ornithine-L-Aspartate; L-Histidine; L-Proline; D-Sorbitol; Aminoacetic acid. | Intravenous infusion solution | 3004.90.99 |
| 25 | Finished pharmaceutical product containing: L-Isoleucine; L-Leucine; L-Lysine Acetate; L-Methionine; L-Phenylalanine; L-Threonine; L-Tryptophan; L-Valine; L-Alanine; L-Arginine | Intravenous infusion solution | 3004.90.99 |
| 26 | Finished drug product containing: Amlodipine; Atorvastatin | All forms | 3004.90.89 |
| 27 | Finished pharmaceutical product containing: Rabeprazole; Tinidazole; Clarithromycin | Oral form | 3004.20.31 |
| 28 | Finished drug product containing: Dextromethorphan hydrobromide; Anhydrous caffeine; dl-Methylephedrine hydrochloride; Guaifenesin; Chlorpheniramine maleate | Soft capsule | 3004.90.59 |
| 29 | Finished pharmaceutical product containing: Valsartan; Hydrochlorothiazide | All forms | 3004.90.89 |
| 30 | Finished pharmaceutical product containing: Glucosamine sulphate; Chondroitin sulphate | All forms | 3004.90.99 |
| 31 | Finished pharmaceutical product containing: Econazole; Triamcinolone; Gentamycin | Cream for external use | 3004.20.99 |
| 32 | Finished drug product containing: Dextromethorphan HBr; Chlorpheniramine maleate; Guaifenesin; Pseudoephedrine HCl | Syrup | 3004.42.00 |
| 33 | Finished pharmaceutical product containing: L-Arginine Hydrochloride; L-Histidine Hydrochloride H20; L-Isoleucine; L-Leucine; L-Lysine HCl; L-Methionine; L-Phenylalanine... | Intravenous infusion solution | 3004.90.99 |
| 34 | Finished drug product containing: Betamethasone valerate; Neomycin sulphate | All forms | 3004.10.20 |
| 35 | Finished pharmaceutical product containing: Miconazole; Neomycin Sulphate; Betamethasone | All forms | 3004.10.20 |
| 36 | Finished pharmaceutical product containing: Sodium Citrate; Sodium Lauryl Sulphate; Glycerin | All forms | 3004.90.99 |
| 37 | Finished pharmaceutical product containing: Rabeprazole; Ornidazole; Clarithromycin | Oral combination kit | 3004.20.31 |
| 38 | Finished drug product containing: Clindamycin; Clotrimazole | Soft vaginal capsule | 3004.20.99 |
| 39 | Finished pharmaceutical product containing: Lisinopril; Hydrochlorothiazide | Oral form | 3004.90.89 |
| 40 | Finished pharmaceutical product containing: Glycyrrhizin; L-cysteine hydrochloride; Glycine | Injection form | 3004.90.99 |
| 41 | Finished pharmaceutical product containing: Dicyclomine; Simethicone | Oral form | 3004.90.99 |
| 42 | Finished pharmaceutical product containing: Diphenhydramine HCl; Ammonium chloride | Syrup | 3004.90.59 |
| 43 | Finished drug product containing: Azintamide; Pancreatin; Cellulase 4000; Simethicone | Tablet | 3004.90.99 |
| 44 | Finished pharmaceutical product containing: Salbutamol; Bromhexine; Guaiphenesin | Oral form | 3004.90.93 |
| 45 | Finished pharmaceutical product containing: Imipenem; Cilastatin | Powder for injection | 3004.20.99 |
| 46 | Finished drug product containing: Ambroxol HCl; Clenbuterol HCl | Oral form | 3004.90.99 |
| 47 | Finished pharmaceutical product containing: Diphenhydramine HCl; Ammonium Chloride; Sodium Citrate | Syrup | 3004.90.59 |
| 48 | Finished drug product containing: Ascorbic acid; Biotin; Calcium carbonate; Calcium pantothenate; Vitamin B12; WS Spray Dried (PI 1426) E | Oral form | 3004.50.21 |
| 49 | Finished drug product containing: Betamethasone; Dexchlorpheniramine maleate | All forms | 3004.32.90 |
| 50 | Finished drug product containing: Acetaminophen; Tramadol HCl | Oral form | 3004.90.51 |
| 51 | Finished drug product containing: Dexamethasone; Camphor; Menthol | Skin cream | 3004.32.10 |
| 52 | Finished drug product containing: Chloramphenicol; Dexamethasone disodium phosphate; Tetrahydrozoline hydrochloride | Eye drops | 3004.20.79 |
| 53 | Finished pharmaceutical product containing: L-Cystine; Choline hydrogen tartrate | Oral form | 3004.90.99 |
| 54 | Finished pharmaceutical product containing: Thiamine HCl; Riboflavin-5-phosphate sodium; Pyridoxine HCl; Niacinamide; d-Panthenol; Ascorbic acid; Dextrose | Infusion solution | 3004.50.29 |
| 55 | Finished pharmaceutical product containing: Neomycin sulfate; Nystatin; polymyxin B sulfate | Vaginal suppository | 3004.10.20 |
| 56 | Finished pharmaceutical product containing: L-ornithine L-aspartate; Garlic extract; Tocopherol Acetate | Oral form | 3004.50.99 |
| 57 | Finished pharmaceutical product containing: Thiamine, Pyridoxine; Cyanocobalamin | Injection form | 3004.50.29 |
| 58 | Finished drug product containing: Calcium carbonate; Vitamin D3 | Suitable for children, in syrup form | 3004.50.10 |
| 58 | Finished drug product containing: Calcium carbonate; Vitamin D3 | Other forms | 3004.50.99 |
| 59 | Finished drug product containing: Ciprofloxacin; Dexamethasone | Eye drops | 3004.20.99 |
| 60 | Finished pharmaceutical product containing: Terbutaline Sulphate; Bromhexine hydrochloride; Guaifenesin; Menthol | Syrup | 3004.90.59 |
| 61 | Finished drug product containing: Calcium carbonate; Calcium lactate gluconate, cholecalciferol | Oral form | 3004.50.99 |
| 62 | Finished pharmaceutical product containing: Dihydrocodeine bitartrate; Guaifenesin; Dl-methylephedrine HCl; Chlorpheniramine maleate | Oral form | 3004.49.11 |
| 63 | Finished pharmaceutical product containing: Evening primrose oil, calcium (as carbonate); vitamin D3 | Oral form | 3004.50.99 |
| 64 | Finished drug product containing: Clotrimazole; Selenium sulfide | Oral form | 3004.90.99 |
| 65 | Finished drug product containing: Clotrimazole; Miconazole nitrate; Ornidazole | Vaginal suppository | 3004.20.99 |
| 66 | Finished pharmaceutical product containing: Doxylamine succinate; Pyridoxine hydrochloride | Oral form | 3004.50.91 |
| 67 | Finished pharmaceutical product containing: Beta carotene emulsion 30%; tocopherol acetate, ascorbic acid, selenium powder, ubidecarenone, zinc oxide | Oral form | 3004.50.21 |
| 68 | Finished pharmaceutical product containing: Glucosamine sulphate; Chondroitin sulphate, omega 3 -fish oil | All forms | 3004.90.99 |
| 69 | Finished pharmaceutical product containing: Sabalis serrulatae fructus; Solidaginis herba; Hippocastani semen | Tablet | 3004.90.98 |
| 70 | Finished drug product containing: Cefoperazone; Sulbactam | Powder for solution for intramuscular or intravenous injection | 3004.20.99 |
| 71 | Finished pharmaceutical product containing: L-Isoleucine; L-Leucine; L-Lysine Monoacetate; L-Methionine; L-Phenylalanine; L-Threonine; L-Tryptophan; L-Valine; L-Arginine; L-Histidine; Glycine; L-Alanine; L-Proline; L-Serine; Cysteine HCl | Intravenous infusion fluid | 3004.90.99 |
| 72 | Finished drug product containing: Betamethasone; Gentamicin | Cream | 3004.32.90 |
| 73 | Finished drug product containing: Ciprofloxacin hydrochloride; Benzalkonium chloride | Ointment form | 3004.20.91 |
| 74 | Finished drug product containing: Candesartan cilexetil; Hydrochlorothiazide | Tablet | 3004.90.89 |
| 75 | Finished drug product containing: Clindamycin; Miconazole | Vaginal suppository | 3004.20.99 |
| 76 | Finished pharmaceutical product containing: Levodopa; Carbidopa | Film-coated tablet | 3004.90.99 |
| 77 | Finished pharmaceutical product containing: Sulfamethoxazole; Trimethoprim | Oral form | 3004.20.10 |
| 78 | Finished drug product containing: Codeine phosphate; Glyceryl guaiacolate | Oral form | 3004.49.11 |
| 79 | Finished drug product containing Paracetamol, Chlorpheniramine | Tablet | 3004.90.51 |
| 80 | Finished pharmaceutical product containing: Solution A: Glucose; Solution B: Amino acid solution; L-Alanine; L-Arginine; L-Aspartic acid; L-Glutamic acid; Glycine; L-Histidine; L-Isoleucine; L-Lysine HCl; L-Methionine | Peripheral intravenous infusion emulsion | 3004.90.99 |
| 81 | Finished pharmaceutical product containing: Ipratropium bromide; Salbutamol sulphate | Aerosol form | 3004.90.93 |
| 82 | Finished pharmaceutical product containing: Lamivudine; Zidovudine | Oral form | 3004.90.82 |
| 83 | Finished pharmaceutical product containing: Sodium lactate solution (60% w/w); Sodium Chloride; | Infusion solution | 3004.90.91 |
| 84 | Finished drug product containing Paracetamol; Ibuprofen | Tablet | 3004.90.54 |
| 85 | Finished pharmaceutical product containing: Mentha oil; eucalyptus oil; lavender oil | Topical patches | 3005.10.10 |
| 86 | Finished pharmaceutical product containing: Pancreatin | Oral form | 3004.90.99 |
| 87 | Finished pharmaceutical product containing: Magaldrate; Simethicone | Chewable tablet | 3004.90.99 |
| 88 | Finished drug product containing: Chlorpheniramine maleate; Dextromethorphan HBr; | Soft capsule | 3004.90.59 . |
| 89 | Finished drug product containing: Cholecalciferol; Oystershell powder | Oral form | 3004.50.99 |
| 90 | Finished drug product containing: Calcipotriol; Betamethasone | All forms | 3004.32.90 |
| 91 | Finished pharmaceutical product containing: Flupentixol dihydrochloride; Melitracen hydrochloride | Oral form | 3004.90.99 |
| 92 | Finished drug product containing: Clotrimazole; Beclomethasone; Gentamicin, Clioquinol | Cream | 3004.32.90 |
| 93 | Finished drug product containing: Benzalkonium chloride; Chlorhexidine digluconate | Foaming solution for topical use | 3004.90.30 |
| 94 | Finished pharmaceutical product containing: Gentamycin; Dexamethasone | Eye drops/ear drops | 3004.20.99 |
| 95 | Finished pharmaceutical product containing: Glycerol; Vaseline; liquid paraffin | Cream | 3004.90.99 |
| 96 | Finished pharmaceutical product containing: Hydroxy propyl methyl cellulose; dextran 70 | Eye drop solution | 3004.90.99 |
| 97 | Finished drug product containing: Bromhexine HCl; Dextromethorphan HBr; Guaifenesin | Soft capsule | 3004.90.59 |
| 98 | Finished pharmaceutical product containing: Ethinylestradiol; Cyproterone acetate | Oral form | 3004.39.00 |
| 99 | Finished pharmaceutical product containing: Pepsin; Diastase (Alpha Amylase) (1:1200); Dried brewer's yeast | Capsule | 3004.90.99 |
| 100 | Finished pharmaceutical product containing: Neomycin; Gramicidin; fludrocortisone acetate | Eye drops | 3004.10.20 |
| 101 | Finished pharmaceutical product containing: Levonorgestrel (D-Norgestrel); Ethinylestradiol | Oral form | 3004.39.00 |
| 102 | Finished pharmaceutical product containing: Losartan potassium; Hydrochlorothiazide | Oral form | 3004.90.89 |
| 103 | Finished pharmaceutical product containing: Dobutamine Hydrochloride; Dextrose | Infusion solution | 3004.90.89 |
| 104 | Finished pharmaceutical product containing: Diclofenac sodium; Pyridoxol HCl; Thiamine nitrate; Vitamin B12 | Oral form | 3004. 50. 21 |
| 105 | Finished pharmaceutical product containing: Drospirenone; Ethinyl estradiol | Film-coated tablet | 3004.39.00 |
| 106 | Finished pharmaceutical product containing: Sodium chloride; Sodium lactate; Potassium chloride; Calcium chloride. 2H2O | Infusion form | 3004.90.91 |
| 107 | Finished drug product containing: Clindamycin; Benzoyl peroxide | Gel bôi da | 3004.20.99 |
| 108 | Finished drug product containing: Clopidogrel hydrogen sulfate form II; acetylsalicylic acid combined with corn starch | Film-coated tablet | 3004.90.89 |
| 109 | Finished pharmaceutical product containing: Glyburide; Metformin hydrochloride | Tablet | 3004.90.89 |
| 110 | Finished pharmaceutical product containing: L-menthol, methyl salicylate; Dl-camphor; thymol, borneol; diphenhydramine | Plaster | 3005.10.10 |
| 111 | Finished drug product containing Paracetamol; ascorbic acid | Effervescent tablet | 3004.50.91 |
| 112 | Finished pharmaceutical product containing: Synthetic retinol concentrate; Thiamine Nitrate; Hydrochloride; Nicotinamide; Colecalciferol; Riboflavin; Calcium Pantothenate | Sugar-coated tablet | 3004.50.21 |
| 113 | Finished pharmaceutical product containing: Tenofovir disoproxil fumarate; Emtricitabine | Oral form | 3004.90.82 |
| 114 | Finished pharmaceutical product containing: Enalapril maleate; Hydrochlorothiazide | Tablet | 3004.90.89 |
| 115 | Finished drug product containing: Valproic acid; Sodium valproate | Controlled-release film-coated tablet | 3004.90.99 |
| 116 | Finished pharmaceutical product containing: Sodium bicarbonate; Citric acid Anhydrous; Sodium carbonate | Effervescent powder | 3004.90.99 |
| 117 | Finished pharmaceutical product containing: Pancreatin; Fellis bovis extract; Hemicellulase | Enteric-coated tablet | 3004.90.99 |
| 118 | Finished drug product containing: Amoxicillin; Potassium clavulanate | Oral form | 3004.10.16 |
| 118 | Finished drug product containing: Amoxicillin; Potassium clavulanate | Other forms | 3004.10.19 |
| 119 | Finished drug product containing: Adapalene; Benzoyl peroxide | Gel | 3004.90.99 |
| 120 | Finished drug product containing: Adenosine triphosphate; Cocarboxylase; Cyanocobalamin; Nicotinamide | Lyophilized powder for injection | 3004.50.21 |
| 121 | Finished pharmaceutical product containing: L-Isoleucine; L-Leucine; L-Lysine acetate; L-Methionine; N-Acetyl-L-Cysteine; L-Phenylalanine; L-Threonine; L-Tryptophan; L-Valine; L-Arginine; L-Histidine; Aminoacetic acid; L-Alanine; L-Proline; L-Serine | Infusion solution | 3004.90.99 |
| 122 | Finished drug product containing: Desogestrel; Ethinyl estradiol | Oral form | 3004.39.00 |
| 123 | Finished pharmaceutical product containing: Piperaquine tetraphosphate; Dihydroartemisinin | Oral form | 3004.60.10 |
| 124 | Finished drug product containing: Ascorbic acid; calcium pantothenate; L-cysteine | Oral form | 3004.50.21 |
| 125 | Finished pharmaceutical product containing: Vitamin A; Vitamin C, Vitamin E | Oral form | 3004.50.21 |
| 126 | Finished drug product containing: Dextrose monohydrate; Sodium chloride; Sodium lactate; Potassium chloride; Calcium chloride.2H2O; Magnesium chloride hexahydrate; sodium metabisulfite | Peritoneal dialysis solution | 3004.90.91 |
| 127 | Finished pharmaceutical product containing: Dextrose; Sodium Chloride; Sodium metabisulfite; Potassium Acetate; Magnesium Acetate | Infusion fluid | 3004.90.91 |
| 128 | Finished pharmaceutical product containing: Dextrose monohydrate; Sodium Chloride; Sodium metabisulfite; Potassium Acetate; Magnesium Acetate; Sodium Acetate | Infusion fluid | 3004.90.91 |
| 129 | Finished pharmaceutical product containing: Potassium Iodide; sodium iodide | Eye drops | 3004.90.99 |
| 130 | Finished pharmaceutical product containing: Gadopentetate meglumine; Meglumine | Injection form | 3004.90.99 |
| 131 | Finished pharmaceutical product containing: Iron (III) hydroxide polymaltose; Folic acid | Chewable tablet | 3004.50.91 |
| 132 | Finished pharmaceutical product containing: chlormadinone acetate; ethinyl estradiol | Film-coated tablet | 3004.39.00 |
| 133 | Finished pharmaceutical product containing: Estradiol; Dydrogesterone | Film-coated tablet | 3004.39.00 |
| 134 | Finished pharmaceutical product containing: pancreatin; hemicellulase; Ox bile; simethicone | enteric-coated tablet | 3004.90.99 |
| 135 | Finished pharmaceutical product containing: Levofloxacin hemihydrate; Dexamethasone sodium phosphate | Eye drops | 3004.20.99 |
| 136 | Finished pharmaceutical product containing: Fluocinolone Acetonide; Ciclopirox Olamine | Skin cream | 3004.32.40 |
| 137 | Finished pharmaceutical product containing: Fluconazole; Tinidazole | Combination kit containing capsules, film-coated tablets | 3004.20.99 |
| 138 | Finished drug product containing: Fusidic acid; Betamethasone | All forms | 3004.32.90 |
| 139 | Finished drug product containing: Folic acid; Ferrous fumarate | Oral form | 3004.50.91 |
| 140 | Finished drug product containing: Anhydrous sodium sulfate; Sodium bicarbonate; Sodium chloride; Potassium chloride | Powder for oral solution | 3004.90.99 |
| 141 | Finished pharmaceutical product containing: Glucosamine sulphate potassium chloride; Methyl sulphonyl Methane | All forms | 3004.90.99 |
| 142 | Finished pharmaceutical product containing: Ferrous Fumarate; folic acid; vitamin B12 | Oral form | 3004.50.21 |
| 143 | Finished pharmaceutical product containing: Propyphenazone; Diphenylhydramine HCl; Adiphenyl HCl | Oral form | 3004.90.59 |
| 144 | Finished drug product containing: Azithromycin; Secnidazole; Fluconazole | Oral form | 3004.20.91 |
| 145 | Finished pharmaceutical product containing: Thiamine Hydrochloride; Riboflavin; Nicotinamide; Calcium Pantothenate | Oral form | 3004.50.21 |
| 146 | Finished pharmaceutical product containing: Vildagliptin; Metformin HCl | Oral form | 3004.90.89 |
| 147 | Finished drug product containing: Bimatoprost; Timolol | Eye drops | 3004.90.99 |
| 148 | Finished drug product containing: Ursodeoxycholic acid; Thiamine HCl; Riboflavin | Soft capsule | 3004.50.21 |
| 149 | Finished drug product containing: Alpha-amylase; papain; simethicone | Oral form | 3004.90.99 |
| 150 | Finished drug product containing: Sodium alginate; Sodium bicarbonate; Calcium carbonate | Oral suspension | 3004.90.99 |
| 151 | Finished pharmaceutical product containing: Anhydrous gelatin (as modified gelatin); NaCl; Magnesium chloride hexahydrate; KCl; Sodium lactate (as sodium (S)-lactate solution) | Injection form | 3004.90.91 |
| 152 | Finished pharmaceutical product containing: Hypromellose; Carbomer | Eye drops | 3004.90.99 |
| 153 | Finished drug product containing: Betamethasone; Clotrimazole; Gentamicin | Kern | 3004.32.90 |
| 154 | Finished drug product containing: Acetaminophen; Isopropylantipyrine; Anhydrous caffeine | Oral form | 3004.90.51 |
| 155 | Finished pharmaceutical product containing: Gliclazide; Metformin Hydrochloride | Oral form | 3004.90.89 |
| 156 | Finished drug product containing: Clobetasol; Neomycin | Cream for external use | 3004.10.20 |
| 157 | Finished pharmaceutical product containing: Metformin HCl; Glibenclamide | Oral form | 3004.90.89 |
| 158 | Finished drug product containing: Ursodeoxycholic acid; Taurine; white ginseng extract, Thiamine nitrate, Inositol | Soft capsule | 3004.90.99 |
| 159 | Finished pharmaceutical product containing: Gramicidin S; Lidocaine HCl | Lozenge | 3004.20.99 |
| 160 | Finished pharmaceutical product containing: Gestodene; Ethinyl estradiol | Oral form | 3004.39.00 |
| 161 | Finished pharmaceutical product containing: Lactobacillus acidophilus 100.000.000 - 10.000.000.000 cfu; Estriol 0,03mg | Vaginal suppository | 3004.39.00 |
| 162 | Finished pharmaceutical product containing: Folic acid; iron fumarate; Cyanocobalamin; zinc sulfate monohydrate | Oral form | 3004.50.21 |
| 163 | Finished pharmaceutical product containing: Iron fumarate, Pyridoxine HCl; Zinc sulfate; Cyanocobalamin; Folic acid | Oral form | 3004.50.21 |
| 164 | Finished pharmaceutical product containing: Ketoconazole; Clobetasol propionate | Topical preparations | 3004.32.10 |
| 165 | Finished pharmaceutical product containing: Pheniramine maleate; Naphazoline hydrochloride | Eye drops | 3004.90.99 |
| 166 | Finished drug product containing: Beta carotene; dl-alpha tocopherol; Ascorbic acid; Selenium in dried yeast | Oral form | 3004.50.21 |
| 167 | Finished pharmaceutical product containing: Tribasic calcium phosphate; Vitamin A; Vitamin A + D3 | Oral form | 3004.50.21 |
| 168 | Finished pharmaceutical product containing: Diosmin; Hesperidin | Film-coated tablet | 3004.90.99 |
| 169 | Finished pharmaceutical product containing: L-Cysteine; Choline bitartrate | Oral form | 3004.90.99 |
| 170 | Finished drug product containing: Cardus marianus extract, Thiamine nitrate, Nicotinamide, Calcium pantothenate, Vitamin B12; B2, B6 | Oral form | 3004.50.21 |
| 171 | Finished pharmaceutical product containing: Meglumine ioxaglate; Sodium ioxaglate | Injection form | 3004.90.99 |
| 172 | Finished drug product containing: Crataegus extract; Ginkgo biloba extract; Melissa extract; Garlic oil | Oral form | 3004.90.98 |
| 173 | Finished pharmaceutical product containing: Glucosamine sulfate; Chondroitin sulfate, Calcium Carbonate, Vitamin C | Oral form | 3004.50.91 |
| 174 | Finished pharmaceutical product containing: Riboflavin; Nicotinamide; Pyridoxal phosphate; Biotin; Dried coix seed ex. | Oral form | 3004.50.21 |
| 175 | Finished drug product containing: Betamethasone; Salicylic acid | All forms | 3004.32.90 |
| 176 | Finished drug product containing: Aluminium hydroxide; Magnesium hydroxide, Simethicone | Oral form | 3004.90.99 |
| 177 | Finished pharmaceutical product containing: Dextrose; D-Panthenol; Vitamins B1; B2; B6; C; PP | Infusion solution | 3004.50.29 |
| 178 | Finished drug product containing: Cyanocobalamin; Chlorpheniramine maleate; Naphazoline HCl | Eye drops | 3004.50.91 |
| 179 | Finished pharmaceutical product containing: Lactobacillus acidophilus; Lactobacillus bifidus; Streptococcus faecalis | Oral form | 3004.90.99 |
| 180 | Finished pharmaceutical product containing: Precipitated Calcium carbonate; concentrated Cholecalciferol | Oral form | 3004.50.99 |
| 181 | Finished drug product containing: Amlodipine; Atenolol | All forms | 3004.90.89 |
| 182 | Finished pharmaceutical product containing: Tilbroquinol; Tiliquinol; Tiliquinol laurylsulfate | Oral form | 3004.90.99 |
| 183 | Finished pharmaceutical product containing: Purified soybean oil; Purified yolk lecithin | Infusion form | 3004.90.99 |
| 184 | Finished pharmaceutical product containing: Iron (III) Hydroxide Polymaltose; Folic Acid; Ascorbic acid | Oral form | 3004.50.21 |
| 185 | Finished pharmaceutical product containing: Metronidazole; Miconazole nitrate, Lactobacillus acidophilus | Vaginal suppository | 3004.20.99 |
| 186 | Finished pharmaceutical product containing: Sitagliptin phosphate monohydrate; Metformin HCl | Oral form | 3004.90.89 |
| 187 | Finished pharmaceutical product containing: Lidocaine HCl; chamomile flower extract | Gel | 3004.90.49 |
| 188 | Finished pharmaceutical product containing: Ketoconazole; Zinc Pyrithione | Injection form | 3004.90.99 |
| 189 | Finished pharmaceutical product containing: L-Leucine; L-Isoleucine; Lysine Hydrochloride; L-Phenylalanine; L-Threonine; L-Valine; L-Tryptophan; L-Histidine HCl.H2O; L-Methionine | Green rice flakes | 3004.90.99 |
| 190 | Finished pharmaceutical product containing: Saxagliptin; Metformin Hydrochloride | Oral form | 3004.90.89 |
| 191 | Finished drug product containing: Artemether; Lumefantrine | Oral form | 3004.90.64 |
| 192 | Finished drug product containing: Dextromethorphan; Glyceryl guaiacolate (guaifenesin); Chlorpheniramine maleate | Syrup | 3004.90.59 |
| 193 | Finished drug product containing: Aluminium hydroxide; Magnesium trisilicate 4.8-6.2H2O; Activated dimethylpolysiloxane | Oral form | 3004.90.99 |
| 194 | Finished pharmaceutical product containing: Iron III Hydroxide Polymaltose; Folic Acid | Oral form | 3004.50.91 |
| 195 | Finished pharmaceutical product containing: Precipitated Calcium carbonate; Cholecalciferol | Oral form | 3004.50.99 |
| 196 | Finished pharmaceutical product containing: Latanoprost; Timolol maleate | Eye drops | 3004.90.99 |
| 197 | Finished pharmaceutical product containing: Lactobacillus LB 5 billion; fermentation culture medium 80mg in 170mg powder | Oral form | 3004.90.99 |
| 198 | Finished pharmaceutical product containing: Lactobacillus LB 10 billion; fermentation culture medium 160mg in 340mg powder | Oral form | 3004.90.99 |
| 199 | Finished pharmaceutical product containing: Lactobacillus acidophilus; Lactobacillus Bulgaricus | Oral form | 3004.90.99 |
| 200 | Finished pharmaceutical product containing: Lamivudine; Nevirapine; Zidovudine | Oral form | 3004.90.82 |
| 201 | Finished pharmaceutical product containing: Macrogol 4000; Anhydrous Sodium sulfate; Sodium Bicarbonate; Sodium Chloride; Potassium Chloride | Oral form | 3004.90.99 |
| 202 | Finished drug product containing: Chlordiazepoxide; Clidinium bromide | Oral form | 3004.90.99 |
| 203 | Finished pharmaceutical product containing: Lidocaine HCl; Epinephrine bitartrate | Injection form | 3004.90.49 |
| 204 | Finished pharmaceutical product containing: Medium-chain triglycerides; Soya-bean oil, refined; Omega-3-acid triglycerides | Infusion form | 3004.90.99 |
| 205 | Finished pharmaceutical product containing: Soyabean oil; Egg Lecithin; Glycerol | Intravenous infusion emulsion | 3004.90.99 |
| 206 | Finished drug product containing: DL-Methionine; Cysteine hydrochloride | Oral form | 3004.90.99 |
| 207 | Finished pharmaceutical product containing: Fluomethasone pivalate; Clioquinol | Ointment | 3004.32.90 |
| 208 | Finished pharmaceutical product containing: Levodopa; Benserazide HCl | Tablet | 3004.90.99 |
| 209 | Finished pharmaceutical product containing: Magnesium trisilicate; Dry Aluminium hydroxide; Simethicone | Oral form | 3004.90.99 |
| 210 | Finished drug product containing: Folic acid 0.35mg; Iron (III) hydroxide polymaltose complex 357mg | Chewable tablet | 3004.50.91 |
| 211 | Finished drug product containing: DL-Methionine; L-Leucine; L-Valine; L-Isoleucine; L-Threonine; L-Tryptophan; L-Phenylalanine; Lysine HCl; Retinol palmitate; Ergocalciferol; Tocopherol acetate; Thiamine nitrate; Riboflavin; Nicotinamide; Pyridoxine HCl; Calcium pantothenate; Cyanocobalamin | Oral form | 3004.50.21 |
| 212 | Finished drug product containing: Dextromethorphan HBr; Potassium cresolsulfonate; Lysozyme chloride | Capsule | 3004.90.59 |
| 213 | Finished drug product containing Paracetamol; Lidocaine | Injection form | 3004.90.59 |
| 214 | Finished pharmaceutical product containing: Erythromycin; Tretinoin | Gel bôi ngoài da | 3004.20.39300 4. 20. 32 |
| 215 | Finished drug product containing: Bacillus subtilis; Streptococcus faecium | Oral form | 3004.90.99 |
| 216 | Finished drug product containing: Crataegus oxyacantha leaf dry extract; Melissa folium dry extract; Ginkgo biloba leaf dry extract; Garlic oil | Oral form | 3004.90.98 |
| 217 | Finished drug product containing: Amoxicillin; Clavulanic acid | Powder for injection | 3004.10.19 |
| 218 | Finished drug product containing: Alverine citrate; Simethicone | Oral form | 3004.90.99 |
| 219 | Finished pharmaceutical product containing: Metronidazole; Povidone-Iodine | Topical preparations | 3004.20.99 |
| 220 | Finished pharmaceutical product containing: Glucose; Amino acids; Fat Emulsion | Infusion solution | 3004.90.91 |
| 221 | Finished drug product containing: Vitamins B1; B2; B6; B12; PP; Dexpanthenol; Biotin | Injection form | 3004.50.29 |
| 222 | Finished drug product containing: Allantoin; pyridoxine HCl; Tocopherol acetate; aminoethyl sulfonic acid; sodium chondroitin sulfate | Eye drops | 3004.50.29 |
| 223 | Finished pharmaceutical product containing: Glucose; fat emulsion; amino acids; electrolytes | Infusion form | 3004.90.91 |
| 224 | Finished pharmaceutical product containing: Iron sulfate; Folic acid | Oral form | 3004.50.91 |
| 225 | Finished pharmaceutical product containing: Mometasone Furoate; Salicylic acid | Ointment | 3004.32.90 |
| 226 | Finished pharmaceutical product containing: L-Isoleucine; L-Leucine; L-Lysine acetate; L-Methionine; L-Phenylalanine; L-Threonine; L-Tryptophan; L-Valine; L-alanine, L-Arginine; L-Aspartic acid, L-Glutamic acid, L-Histidine, L-Proline,... | intravenous injection | 3004.90.99 |
| 227 | Finished pharmaceutical product containing: L-Isoleucine; L-Leucine; Lysine acetate; L-Methionine; L-Phenylalanine; L-Threonine; L-Tryptophan; L-Valine; L-Alanine; L-Arginine; L-Aspartic acid; L-cysteine; L-.... | Infusion emulsion | 3004.90.99 |
| 228 | Finished pharmaceutical product containing: Thiamine hydrochloride; Riboflavin; Pyridoxine hydrochloride; Nicotinamide | Oral form | 3004.50.10 |
| 229 | Finished pharmaceutical product containing: Vitamin A Acetate, Vitamin D3, Vitamin B1, Vitamin B2, Vitamin B6, Nicotinamide, Cyanocobalamin, Calcium Pantothenate, Folic acid, Vitamin C, Vitamin E, Ferrous sulphate, Cupric sulphate, Manganese sulphate, Zinc sulphate; Potassium iodide; Potassium sulphate | Oral form | 3004.50.21 |
| 230 | Finished pharmaceutical product containing: Tropicamide; Phenylephrine HCl | Eye drops | 3004.49.90 |
| 231 | Finished drug product containing: Chlorpheniramine; Dextromethorphan; Phenylephrine | Soft capsule | 3004.90.59 |
| 232 | Finished pharmaceutical product containing: Dextrose; D-Pantothenol; Ascorbic acid; Thiamine hydrochloride; Riboflavin; Niacinamide; Pyridoxine hydrochloride | Intravenous infusion solution | 3004.50.29 |
| 233 | Finished pharmaceutical product containing: Magnesium Lactate; Pyridoxine hydrochloride | Oral form | 3004.50.91 |
| 234 | Finished pharmaceutical product containing: Metformin Hydrochloride; Glimepiride | Oral form | 3004.90.89 |
| 235 | Finished drug product containing: Clotrimazole; Gentamicin sulfate; Beclomethasone dipropionate | Skin cream | 3004.32.90 |
| 236 | Finished pharmaceutical product containing: L-Isoleucine; L-Leucine; L-Lysine acetate; L-Methionine; L-Phenylalanine; L-Threonine; L-Tryptophan; L-Valine; L-alanine, L-Arginine; L-Aspartic acid, L-Glutamic acid, L-Histidine, L-Proline,... | intravenous injection | 3004.90.99 |
| 237 | Finished drug product containing: Codeine base (as codeine camphosulfonate); Sulfoguaiacol; Grindelia soft extract | Oral form | 3004.49.11 |
| 238 | Finished pharmaceutical product containing: Metronidazole; Miconazole nitrate | Vaginal suppository | 3004.20.99 |
| 239 | Finished drug product containing: Alpha-amylase; papain; dill oil, anise oil, caraway oil | Oral form | 3004.90.99 |
| 240 | Finished drug product containing: Alpha amylase; Papain | Liquid medicine | 3004.90.99 |
| 241 | Finished pharmaceutical product containing: Metronidazole; Neomycin sulfate; Nystatin | Vaginal suppository | 3004.10.20 |
| 242 | Finished pharmaceutical product containing: L-Isoleucine; L-Leucine; L-Lysine Acetate; L-Methionine; L-Phenylalanine; L-Threonine; L-Tryptophan; L-Valine; L-Histidine; L-cysteine.HCl.2H2O; Sodium Bisulfite; Disodium Edetate | Infusion solution | 3004.90.99 |
| 243 | Finished pharmaceutical product containing: L-Isoleucine; L-Leucine; L-alanine, L-Arginine; L-Methionine; L-phenylalanine; L-Proline,... | Solution for intravenous infusion | 3004.90.99 |
| 244 | Finished drug product containing: Cytidine-5'-monophosphate disodium (CMP, disodium salt); Uridine-5'-triphosphate trisodium (UTP, sodium salt) + Uridine-5'-diphosphate disodium (UDP, sodium salt) + Uridine-5'-monophosphate disodium (UMP, sodium salt) | Injection form | 3004.90.99 |
| 245 | Finished drug product containing: Cytidine-5-disodium monophosphate; Uridine-5-trisodium triphosphate; Uridine-5-disodium diphosphate; Uridine-5-disodium monophosphate | Oral form | 3004.90.99 |
| 246 | Finished drug product containing: Cytidine-5-disodium monophosphate; Uridine-5-trisodium triphosphate; Uridine-5-disodium diphosphate; Uridine-5-disodium monophosphate | Injection form | 3004.90.99 |
| 247 | Finished drug product containing: Carbonyl iron; Folic acid; B12; Vitamin C; Zinc sulphate | Oral form | 3004.50.21 |
| 248 | Finished pharmaceutical product containing: Lutein; Zeaxanthin; Ascorbic acid; alpha-tocopheryl acetate; Selenium; Zinc | Oral form | 3004.50.21 |
| 249 | Finished pharmaceutical product containing: Dihydroergocristine mesylate 333,0mcg; Dihydroergocryptine mesylate 333,0mcg; Dihydroergocornine mesylate 333,0mcg (equivalent to Dihydroergotoxine mesylate 1 mg) | Oral form | 3004.49.90 |
| 250 | Finished pharmaceutical product containing: Olmesartan medoxomil; Hydrochlorothiazide | Oral form | 3004.90.89 |
| 251 | Finished pharmaceutical product containing: Oxethazaine; Anhydrous aluminium hydroxide gel; Magnesium hydroxide | Oral form | 3004.90.99 |
| 252 | Finished pharmaceutical product containing: Polymyxin B sulfate; Neomycin sulfate; Gramicidin | Eye drops | 3004.10.20 |
| 253 | Finished drug product containing: Sodium carboxymethylcellulose; Glycerin; polysorbate | Eye drops | 3004.90.99 |
| 254 | Finished pharmaceutical product containing: Ofloxacin; Hydroxy PropylMethylCellulose | Eye drops | 3004.20.99 |
| 255 | Finished pharmaceutical product containing: Dried aluminium hydroxide gel; Magnesium trisilicate, Magnesium Hydroxide, Simethicone | Chewable tablet | 3004.90.99 |
| 256 | Finished drug product containing: Calcium; Alfacalcidol | Oral form | 3004.50.99 |
| 257 | Finished pharmaceutical product containing: Phenazone; Lidocaine HCl | Ear drop solution | 3004.90.49 |
| 258 | Finished pharmaceutical product containing: Dimethicone; Dried Aluminium hydroxide gel; Magnesium hydroxide | Chewable tablet | 3004.90.99 |
| 259 | Finished drug product containing: Chlorpheniramine maleate; DL-Methylephedrine HCl, Dextromethorphan HBr | Capsule | 3004.49.90 |
| 260 | Finished drug product containing: Beta carotene; natural Vitamin E; Selenium, alpha lipoic acid | Oral form | 3004.50.21 |
| 261 | Finished pharmaceutical product containing: Pantoprazole Sodium sesquihydrate; Clarithromycin; Amoxicillin Trihydrate | Oral form | 3004.10.16 |
| 262 | Finished drug product containing Paracetamol; Phenylephrine hydrochloride; Noscapine; Caffeine; Vitamin C; Terpin Hydrate | Tablet | 3004.90.51 |
| 263 | Finished drug product containing Paracetamol; Caffeine | Effervescent tablet | 3004.90.51 |
| 264 | Finished pharmaceutical product containing: Magnesium aspartate; Potassium aspartate | Injection form | 3004.90.99 |
| 265 | Finished pharmaceutical product containing: Magnesium aspartate tetrahydrate; Potassium aspartate hemihydrate | Oral form | 3004.90.99 |
| 266 | Finished pharmaceutical product containing: Pancreatin; Dimethicone | Tablet | 3004.90.99 |
| 267 | Finished drug product containing Paracetamol; thiamine nitrate; chlorpheniramine maleate | Granules for oral suspension | 3004.90.51 |
| 268 | Finished pharmaceutical product containing: Pantoprazole; Tinidazole; Clarithromycin | Combination kit containing film-coated tablets | 3004.20.31 |
| 269 | Finished pharmaceutical product containing: Sulfogaiacol; Sodium benzoate | Syrup | 3004.90.59 |
| 270 | Finished pharmaceutical product containing: Neomycin Sulfate; Bacitracin Zinc; Amylocaine HCl | Lozenge tablet | 3004.10.20 |
| 271 | Finished pharmaceutical product containing: Vitamin B9 (Folic acid); Vitamin B12 (Cyanocobalamin); Biotin; Ferrous fumarate; Ascorbic acid | Oral form | 3004.50.21 |
| 272 | Finished pharmaceutical product containing: Sodium chloride; Tri-sodium citrate dihydrate; potassium chloride; anhydrous dextrose | Powder for oral use | 3004.90.99 |
| 273 | Finished pharmaceutical product containing: Polyethylene glycol; sodium chloride, potassium chloride, sodium bicarbonate, anhydrous Sodium sulphate | Oral form | 3004.90.99 |
| 274 | Finished drug product containing: Bacillus subtilis; Streptococcus faecium, thiamine HCl, riboflavin, nicotinamide, pyridoxine HCl, Vitamin C, Cyanocobalamin, Ca, Zn | Oral form | 3004.50.21 |
| 275 | Finished pharmaceutical product containing: Dried aluminium hydroxide; Magnesium trisilicate, Magnesium Hydroxide, Simethicone | Chewable tablet | 3004.90.99 |
| 276 | Finished pharmaceutical product containing: Perindopril tert Butylamine; Indapamide | Oral form | 3004.90.89 |
| 277 | Finished pharmaceutical product containing: Metformin Hydrochloride; Pioglitazone Hydrochloride | Oral form | 3004.90.89 |
| 278 | Finished pharmaceutical product containing: Felodipine; Metoprolol succinate | Oral form | 3004.90.89 |
| 279 | Finished drug product containing: Calcium lactate gluconate; Calcium carbonate; Ascorbic acid | Oral form | 3004.50.91 |
| 280 | Finished pharmaceutical product containing: Glucosamine sulfate potassium chloride; Manganese sulfate; | Oral form | 3004.50.21 |
| 281 | Finished pharmaceutical product containing: Natural fish oil (Tuna); Omega-3 marine | Oral form | 3004.50.21 |
| 282 | Finished drug product containing: Dexamethasone sodium phosphate; Ofloxacin | Eye drops | 3004.20.99 |
| 283 | Finished pharmaceutical product containing: Neomycin sulfate; Polymyxin B sulfate; Sodium | Ear drop solution | 3004.10.20 |
| 284 | Finished pharmaceutical product containing: Pantoprazole; Tinidazole | enteric-coated tablet | 3004.20.31 |
| 285 | Finished pharmaceutical product containing: Polymyxin B sulfate; Neomycin sulfate; Dexamethasone[2] | Eye drops | 3004.32.90 |
| 286 | Finished pharmaceutical product containing: Trimebutine; Ruscogenins | Rectal cream | 3004.90.99 |
| 287 | Finished pharmaceutical product containing: Lansoprazole; Amoxicillin; Clarithromycin | Oral form | 3004.10.16 |
| 288 | Finished drug product containing Paracetamol; tramadol | Oral form | 3004. 90. 51 |
| 289 | Finished pharmaceutical product containing: Pinene; Camphene; Borneol; Menthone; Menthol; | Oral form | 3004.90.99 |
| 290 | Finished pharmaceutical product containing: Pinene, Camphene, Borneol, Fenchone; Anethole; | Oral form | 3004.90.99 |
| 291 | Finished pharmaceutical product containing: Thiamine hydrochloride; Riboflavin; Pyridoxine hydrochloride; Nicotinamide; Dexpanthenol; | Injection form | 3004.50.29 |
| 292 | Finished drug product containing: Chloramphenicol; Dexamethasone | Eye drops | 3004.20.79 |
| 293 | Finished pharmaceutical product containing: Ramipril; hydrochlorothiazide | Oral form | 3004.90.89 |
| 294 | Finished pharmaceutical product containing: Sodium succinate; N-(1-deoxy-D-glucitol-1-yl)-N-methylammonium | Infusion form | 3004.90.99 |
| 295 | Finished pharmaceutical product containing: Vitamin C; Zinc | Oral form | 3004.50.91 |
| 296 | Finished drug product containing: Amiloride hydrochloride; Hydrochlorothiazide | Oral form | 3004.90.89 |
| 297 | Finished drug product containing: Carbocisteine; Promethazine HCl | Oral form | 3004.90.59 |
| 298 | Finished drug product containing: Acetaminophen; Dextromethorphan HBr; Phenylephrine HCl | Oral form | 3004. 90. 51 |
| 299 | Finished drug product containing: Acetaminophen; Dextromethorphan HBr; Doxylamine succinate | Oral form | 3004. 90. 51 |
| 300 | Finished drug product containing: Amoxicillin; Potassium clavulanate | Oral form | 3004.10.16 |
| 301 | Finished pharmaceutical product containing: Ethinyl Oestradiol; Levonorgestrel | Coated tablet | 3004.39.00 |
| 302 | Finished pharmaceutical product containing: Sodium Lactate solution, Sodium chloride; Potassium Chloride; Calcium Chloride | Intravenous infusion form | 3004.90.91 |
| 303 | Finished pharmaceutical product containing: Pseudoephedrine HCl; Triprolidine HCl | Oral form | 3004.42.00 |
| 304 | Finished drug product containing: 2,4 Dichlorobenzyl Alcohol; Amylmetacresol; menthol | Lozenge | 3004.90.99 |
| 305 | Finished pharmaceutical product containing: Sodium lactate solution (60% w/w); Sodium Chloride; Potassium Chloride; Calcium Chloride dihydrate | Infusion form | 3004.90.91 |
| 306 | Finished pharmaceutical product containing: Sodium Chloride, Potassium Chloride, Calcium Chloride Dihydrate; Magnesium Chloride Hexahydrate, Sodium Acetate Trihydrate, Malic acid | Infusion form | 3004.90.91 |
| 307 | Finished pharmaceutical product containing: Pinene (alpha + beta); Camphene; Cineol; Menthol; Menthone; Borneol | Oral form | 3004.90.99 |
| 308 | Finished pharmaceutical product containing: Pinene (alpha+beta); Camphene; Cineol BPC (1973); Fenchone; Borneol; Anethole | Oral form | 3004.90.99 |
| 309 | Finished pharmaceutical product containing: Royal Jelly; Aloe extract, retinol acetate, Ferrous fumarate, Magnesium oxide, Zinc oxide, Dibasic calcium phosphate, palm oil | Oral form | 3004.90.98 |
| 310 | Finished pharmaceutical product containing: Neomycin sulfate; Clotrimazole; Metronidazole | Vaginal suppository | 3004.10.20 |
| 311 | Finished pharmaceutical product containing: Methyl salicylate; Turpentine oil; White camphor oil; Cinnamic aldehyde oil; Cinnamon leaf oil | Rubbing oil | 3004.90.55 |
| 312 | Finished pharmaceutical product containing: Salbutamol; Beclomethasone Dipropionate | Nebulizer / aerosol | 3004. 32. 90 |
| 313 | Finished pharmaceutical product containing: Iron Gluconate; Manganese sulfate; Copper sulfate; | Oral form | 3004.90.99 |
| 314 | Finished pharmaceutical product containing: sulphur; Salicylic acid | Medicated soap | 3401.11.40 |
| 315 | Finished drug product containing: Cefixime; Lactic acid bacillus | Oral form | 3004.20.91 |
| 316 | Finished drug product containing: Cod liver oil; Vitamin A and D3 oily concentrate; Calcium hypophosphite | Oral form | 3004.50.21 |
| 317 | Finished drug product containing: Betamethasone; d-Chlorpheniramine maleate | Tablet | 3004.32.90 |
| 318 | Finished drug product containing: Creosote; Powdered geranium herb; Phellodendron bark dry extract | Oral form | 3004.90.98 |
| 319 | Finished pharmaceutical product containing: L-Isoleucine; L-Leucine; L-valine | Film-coated granules | 3004.90.99 |
| 320 | Finished pharmaceutical product containing: Selenium in dried yeast; chromium in dried yeast; ascorbic acid | Oral form | 3004.50.91 |
| 321 | Finished drug product containing: Calcium lactate; Calcium gluconate; Calcium carbonate; ergocalciferol granules | Oral form | 3004.50.99 |
| 322 | Finished pharmaceutical product containing: Sulphamethoxazole; Trimethoprim | Oral form | 3004.20.10 |
| 323 | Finished drug product containing: Articaine hydrochloride; Adrenaline base | Injection solution for dental use | 3004.39.00 |
| 324 | Finished pharmaceutical product containing: Fluticasone propionate; Salmeterol Xinafoate | Metered-dose spray suspension | 3004.32.90 |
| 325 | Finished pharmaceutical product containing: Fluticasone propionate; Salmeterol Xinafoate | Suspension-type inhalation spray for oral inhalation | 3004.32.90 |
| 326 | Finished pharmaceutical product containing: Salmeterol xinafoate; Fluticasone propionate | Metered-dose aerosol spray | 3004.32.90 |
| 327 | Finished drug product containing: Amoxicillin trihydrate; potassium clavulanate | Injection form | 3004.10.19 |
| 328 | Finished drug product containing: Ampicillin sodium; Sulbactam sodium | Injection form | 3004.10.19 |
| 329 | Finished pharmaceutical product containing: Concentrated hydrolyzed liver protein (65%); Concentrated Peptone (65%); Ferric Ammonium citrate (50%v/v); Folic Acid | Oral form | 3004.50.91 |
| 330 | Finished pharmaceutical product containing: L-Cysteine; Choline Hydrogen tartrate | Oral form | 3004.90.99 |
| 331 | Finished drug product containing: Calcium gluconate; Calcium saccharate | Injection form | 3004.90.99 |
| 332 | Finished pharmaceutical product containing: Dimethyl polysiloxane; Magaldrate | Oral form | 3004.90.99 |
| 333 | Finished drug product containing: Calcium lactate; Calcium gluconate hydrate; Calcium carbonate; Anhydrous ergocalciferol | Oral form | 3004.50.99 |
| 334 | Finished pharmaceutical product containing: Gentamycin sulfate; Lidocaine HCl | Injection solution | 3004.20.99 |
| 335 | Finished pharmaceutical product containing: Urea; Vitamin E | Cream for external use | 3004.50.99 |
| 336 | Finished pharmaceutical product containing: Refined soybean oil; Medium chain triglycerides; Refined olive oil; Refined fish oil | Intravenous infusion emulsion | 3004.90.99 |
| 337 | Finished pharmaceutical product containing: Sodium Lactate; Sodium Chloride; Potassium Chloride; Calcium Chloride | Infusion form | 3004.90.91 |
| 338 | Finished drug product containing: Dextromethorphan HBr; Phenylephrine HCl; Chlorpheniramine maleate | Oral form | 3004.90.59 |
| 339 | Finished pharmaceutical product containing: L-cystine; Precipitated sulphur; Retino | Oral form | 3004.50.91 |
| 340 | Finished pharmaceutical product containing: Sodium chloride; sodium bicarbonate | Concentrated hemodialysis solution | 3004.90.91 |
| 341 | Finished pharmaceutical product containing: Vitamin B1; B2; B6; B12; nicotinamide; sodium pantothenate; biotin; folic acid | Powder for solution for infusion | 3004.50.29 |
| 342 | Finished drug product containing: Atropine sulfate; Hyoscyamine sulfate; Scopolamine HBr; Phenobarbital | Oral form | 3004.49.70 |
| 343 | Finished pharmaceutical product containing: Dicyclomine HCl; Propoxyphene Napsylate, Acetaminophen | Capsule | 3004. 90. 51 |
| 344 | Finished drug product containing: Antazoline hydrochloride; Tetryzoline hydrochloride | Eye drops | 3004.90.99 |
| 345 | Finished pharmaceutical product containing: Spiramycin; Metronidazole | Film-coated tablet | 3004.20.31 |
| 346 | Finished pharmaceutical product containing: Esdepallethrin; piperonyl butoxide | Topical spray solution | 3004.90.99 |
| 347 | Finished drug product containing: Calcium carbonate; Cholecalciferol; Magnesium sulphate | Film-coated tablet | 3004.50.99 |
| 348 | Finished drug product containing: 2,4 Dichlorobenzyl (Dybenal); Amylmetacresol | Lozenge | 3004.90.59 |
| 349 | Finished drug product containing: 2,4 Dichlorobenzyl (Dybenal); Amylmetacresol, Vitamin C | Lozenge | 3004.50.91 |
| 350 | Finished drug product containing: Ampicillin; Sulbactam | Injection form | 3004.10.19 |
| 351 | Finished pharmaceutical product containing: Vitamin A; B1, B2, B6, B12, D3, E, C, calcium Pantothenate, folic acid, calcium zinc,... | Oral form | 3004.50.21 |
| 352 | Finished drug product containing: Budesonide; Formoterol fumarate dihydrate | Powder for inhalation | 3004.32.90 |
| 353 | Finished pharmaceutical product containing: Metronidazole; Chlorhexidine | Gel bôi răng | 3004.20.99 |
| 354 | Finished pharmaceutical product containing: Tenofovir Disoproxil Fumarate; Lamivudine | Oral form | 3004.90.82 |
| 355 | Finished pharmaceutical product containing: Polymethylene Glycol 400; propylene Glycol | Eye drops | 3004.90.99 |
| 356 | Finished pharmaceutical product containing: Menthol; Methyl salicylate; Camphor; Thymol | Plaster | 3005.10.10 |
| 357 | Finished pharmaceutical product containing: Oxycodone HCl; Naloxone HCl | Oral form | 3004.49.11 |
| 358 | Finished pharmaceutical product containing: Meglumine ioxitalamate; Sodium ioxitalamate | Injection form | 3004.90.99 |
| 359 | Finished pharmaceutical product containing: Hydroxypropyl methylcellulose 2910; Dextran 70 | Eye drops | 3004.90.99 |
| 360 | Finished pharmaceutical product containing: Tenofovir disoproxil fumarate; Lamivudine; Efavirenz | Oral form | 3004.90.82 |
| 361 | Finished pharmaceutical product containing: Terbutaline Sulphate; Ambroxol hydrochloride; Guaifenesin; Levomenthol | Oral form | 3004.90.99 |
| 362 | Finished pharmaceutical product containing: Ticarcillin disodium; Clavulanate potassium | Injection form | 3004.10.19 |
| 363 | Finished pharmaceutical product containing: Ticarcillin; Clavulanic acid | Injection form | 3004.10.19 |
| 364 | Finished pharmaceutical product containing: Terbutaline Sulfate; Glyceryl guaiacolate | Oral form | 3004.90.99 |
| 365 | Finished pharmaceutical product containing: Oyster Shell Powder; Dry Cholecalciferol | Oral form | 3004.50.99 |
| 366 | Finished pharmaceutical product containing: Terbutaline Sulphate 1,5mg; Guaiphenesine 50mg; | Oral form | 3004.90.99 |
| 367 | Finished pharmaceutical product containing: Iron Gluconate; Manganese Gluconate; Copper Gluconate | Oral solution | 3004.90.99 |
| 368 | Finished pharmaceutical product containing: Precipitated Calcium carbonate; Cholecalciferol | Oral form | 3004.50.99 |
| 369 | Finished pharmaceutical product containing: Sodium Lactate; Potassium Chloride; Calcium Chloride | Infusion form | 3004.90.99 |
| 370 | Finished pharmaceutical product containing: Tegafur; Gimeracil; Oteracil potassium | Oral form | 3004.90.89 |
| 371 | Finished pharmaceutical product containing: Terbutaline Sulphate; Bromhexine hydrochloride; Guaifenesin; Menthol | Syrup | 3004.90.99 |
| 372 | Finished drug product containing: Silver sulphadiazine; Chlorhexidine gluconate solution | Ointment for external use on the skin | 3004.90.30 |
| 373 | Finished drug product containing: Salts; Iron chloride; Zinc chloride; Manganese chloride; Copper chloride; Chromium chloride; Sodium selenite; Potassium iodide;... | Infusion form | 3004.90.99 |
| 374 | Finished pharmaceutical product containing: Linagliptin; Metformin hydrochloride | Oral form | 3004.90.89 |
| 375 | Finished pharmaceutical product containing: Dried aluminium hydroxide gel Magnesium hydroxide bled; Oxethazaine | Oral form | 3004.90.99 |
| 376 | Finished pharmaceutical product containing: Neomycin; Dexamethasone | Eye drops | 3004.10.20 |
| 377 | Finished pharmaceutical product containing: Losartan; Amlodipine | All forms | 3004.90.89 |
| 378 | Finished pharmaceutical product containing: Efavirenz; Emtricitabine; Tenofovir disoproxil fumarate | Film-coated tablet | 3004.90.82 |
| 379 | Finished pharmaceutical product containing: EPA (Eicosapentaenoic acid); DHA (Docosahexaenoic Acid); Vitamin E | Oral form | 3004.90.82 |
| 380 | Finished pharmaceutical product containing: Indacaterol; Glycopyrronium | Oral form | 3004.90.99 |
| 381 | Finished pharmaceutical product containing: Triamcinolone acetonide; Neomycin Sulphate; Nystatin; Clotrimazole | Skin cream | 3004.10.20 |
| 382 | Finished drug product containing: Colloidal aluminium phosphate; Magnesium oxide | Oral form | 3004.90.99 |
| 383 | Finished pharmaceutical product containing: Sodium amidotrizoate; Meglumine amidotrizoate | Injection form | 3004.90.99 |
| 384 | Finished pharmaceutical product containing: Metronidazole; Clotrimazole; Lactic acid bacillus | Oral form | 3004.20.99 |
| 385 | Finished drug product containing: Crataegus extract; Ginkgo biloba extract; Melissa extract; Garlic oil | Oral form | 3004.90.98 |
| 386 | Finished pharmaceutical product containing: Salbutamol sulphate; Guaiphenesin | Oral form | 3004.90.93 |
| 387 | Finished drug product containing: Clindamycin; Adapalene | Gel | 3004.20.99 |
| 388 | Finished drug product containing: Dextromethorphan HBr; Phenylephrine HCl; Cetirizine HCl; Racementhol | Syrup | 3004. 90. 59 |
| 389 | Finished pharmaceutical product containing: Vitamin B1; B2; B6; Nicotinamide; Sodium Pantothenate | Injection form | 3004.50.91 |
| 390 | Finished pharmaceutical product containing: Vitamin B1; Vitamin B6; | Oral form | 3004.50.21 |
| 391 | Finished drug product containing: Beta-carotene; Dl-alpha-tocopherol acetate; ascorbic acid; Zinc oxide, Cupric oxide; Selenium; Manganese sulfate | Oral form | 3004.50.21 |
| 392 | Finished pharmaceutical product containing: Poly (O-2-hydroxyethyl) starch (HES 130/0,4); Sodium acetate trihydrate; Sodium chloride; Potassium chloride; Magnesium chloride hexahydrate | Infusion form | 3004.90.91 |
| 393 | Finished pharmaceutical product containing: Ezetimibe; Simvastatin | Oral form | 3004.90.99 |
| 394 | Finished pharmaceutical product containing: Levodopa; Carbidopa | Tablet | 3004.90.89 |
| 395 | Finished pharmaceutical product containing: L-Cysteine; Ascorbic acid, Ursodeoxycholic acid, Vitamin E, Ubidecarenone, Thiamine Nitrate, Calcium Pantothenate | Oral form | 3004.50.21 |
| 396 | Finished pharmaceutical product containing: Magnesium Aluminium hydroxide; Magnesium Aluminium silicate; Magnesium oxide; Ranitidine | Oral form | 3004.90.94 |
| 397 | Finished drug product containing: Calcium carbonate; cholecalciferol concentrated powder | Oral form | 3004.50.99 |
| 398 | Finished drug product containing: Ampicillin sodium; Cloxacillin sodium | Injection form | 3004.10.19 |
| 399 | Finished pharmaceutical product containing: Lidocaine; Prilocaine | Topical cream | 3004.90.49 |
| 400 | Finished pharmaceutical product containing: Crataegi extract; Melissa folium extract; Ginkgo biloba leaf extract, Garlic oil | Oral form | 3004.90.98 |
| 401 | Finished pharmaceutical product containing: Magnesium hydroxide, Aluminium hydroxide (as dry gel); Dimethylpolysiloxane | Oral form | 3004.90.99 |
| 402 | Finished pharmaceutical product containing: Methyl salicylate; L-Menthol | Lotion | 3004.90.59 |
| 403 | Finished pharmaceutical product containing: Thiamine nitrate, Riboflavin, Pyridoxine HCl 97% DC, Cyanocobalamin 1% SD, ascorbic acid 97% DC; Calcium pantothenate, nicotinamide | Oral form | 3004.90.55 |
| 404 | Finished drug product containing: Clindamycin phosphate; Clotrimazole; Metronidazole | Vaginal suppository | 3004.20.99 |
| 405 | Finished pharmaceutical product containing: Elbasvir; Grazoprevir | Oral form | 3004.90.89 |
| 406 | Finished pharmaceutical product containing: Miconazole Nitrate; Tinidazole | Vaginal suppository | 3004.20.99 |
| 407 | Finished pharmaceutical product containing: Unithiol; Calcium pantothenate | Oral form | 3004.90.99 |
| 408 | Finished pharmaceutical product containing: Dolutegravir, Lamivudine, tenofovir | Oral form | 3004.90.82 |
| 409 | Finished pharmaceutical product containing: Sofosbuvir; Velpatasvir | Oral form | 3004.90.89 |
| 410 | Finished drug product containing: Brinzolamide; Brimonidine | Eye drops | 3004.90.99 |
| 411 | Finished drug product containing: Atorvastatin, Perindopril, Amlodipine | Oral form | 3004.90.89 |
| 412 | Finished drug product containing: Dapagliflozin; Metformin | Oral form | 3004.90.89 |
| 413 | Finished pharmaceutical product containing: Sacubitril, Valsartan | Oral form | 3004.90.89 |
| 414 | Finished pharmaceutical product containing: umeclidinium, vilanterol | Metered-dose inhalation powder | 3004.90.99 |
| 415 | Finished pharmaceutical product containing: Pravastatin; Fenofibrate | Oral form | 3004.90.89 |
| 416 | Finished pharmaceutical product containing: Ledipasvir; Sofosbuvir | Oral form | 3004.90.99 |
| 417 | Finished pharmaceutical product containing: Netupitant; Palonosetron | Oral form | 3004.90.99 |
| 418 | Finished pharmaceutical product containing: Drospirenone; Ethinyl estradiol | Oral form | 3004.39.00 |
| 419 | Finished pharmaceutical product containing: Metoprolol tartrate; Ivabradine | Oral form | 3004.90.89 |
| 420 | Finished pharmaceutical product containing: Tetrakis (2-methoxy isobutyl isonitrile) copper (I) tetrafluoroborate | Lyophilized powder for injection | 3004.90.99 |
| 421 | Finished pharmaceutical product containing: Sodium molybdate 5-50GBq; Sodium pertechnetate | Elution solution for injection | 3004.90.99 |
| 422 | Finished pharmaceutical product containing: Tiotropium; Olodaterol | Inhalation solution | 3004.90.89 |
| 423 | Finished pharmaceutical product containing: umeclidinium, vilanterol, fluticasone furoate | Metered-dose inhalation powder | 3004.32.90 |
| 424 | Finished drug product containing vilanterol, fluticasone furoate | Metered-dose inhalation powder | 3004.32.90 |
| 425 | Finished pharmaceutical product containing: Dutasteride, Tamsulosin hydrochloride | Hard capsule | 3004.39.00 |
This digitised text is for reference, and its formatting may differ slightly from the original. For legal purposes, please verify against the attached original or the Official Gazette. The authoritative text is in Vietnamese.